News
A University of Dundee spinout has announced a multi-million pound deal to develop first-in-class therapeutics that restore the body's natural disease suppression processes.
News
A University of Dundee spinout has announced a multi-million pound deal to develop first-in-class therapeutics that restore the body's natural disease suppression processes.
Press release
Some of Scotland’s brightest business prospects are preparing for an exciting future after being crowned winners of a major Scottish competition.
News
Parliamentarians from across the political spectrum today heard how University of Dundee research could help save millions of lives in low- and middle-income countries (LMICs)
News
Professor Mike Bodkin has joined the School of Life Sciences to head up computational drug discovery within the Drug Discovery Unit (DDU).
News
The Drug Discovery Unit (DDU) is delighted to announce that Professor Ian Gilbert has been appointed to be the Head of the Drug Discovery Unit
News
Professor Paul Wyatt, Head of the Drug Discovery Unit (DDU), Director of the Wellcome Centre for Anti-Infectives Research is leaving the University to take up a new role at Sitala Bio Ltd.
Press release
Three spinout projects from the University of Dundee with the potential to deliver significant healthcare benefits have received more than £250,000 from Scottish Enterprise to support their development.
Press release
The Universities of Dundee and Edinburgh are playing key roles in a €77.7 million pan-European consortium seeking to accelerate the development of therapies for Covid-19 and future coronaviruses.
Press release
The University of Dundee is working with partners around the world to rapidly repurpose existing drugs against Covid-19.
News
David Gray has been promoted to Personal Chair. He takes the title of Professor of Translational Biology which is in recognition of his extensive work within the Drug Discovery Unit (DDU) and Wellcome Centre for Anti-Infectives Research (WCAIR).
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).